Hironori Ashinuma1, Masato Shingyoji2, Yasushi Yoshida2, Meiji Itakura2, Toshihiko Iizasa3, Yoshihiko Sakashita4, Ikuo Sekine2,5. 1. Division of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan. hashinuma@chiba-cc.jp. 2. Division of Respiratory Medicine, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba City, Chiba, 260-8717, Japan. 3. Division of Thoracic Surgery, Chiba Cancer Center, Chiba, Japan. 4. Division of Palliative Care, Chiba Cancer Center, Chiba, Japan. 5. Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaragi, 305-8575, Japan.
Abstract
BACKGROUND: It is not uncommon for patients with lung cancer to receive supportive care alone. However, the clinical characteristics of these patients have not been fully studied. We conducted a retrospective study to identify the clinical characteristics of definitive lung cancer patients treated with supportive care alone. METHODS: We retrospectively analyzed the percentage of and reasons for definitive lung cancer patients treated with supportive care alone at a regional cancer center. We also investigated the histological diagnostic approaches, palliative therapy types, primary treatment locations after hospital consultation, and places of death. RESULTS: A total of 1,223 patients were histologically diagnosed as having lung cancer between 2011 and 2014. Of these, 160 (13%) patients were treated with supportive care alone. The primary reason for treatment with supportive care alone was a poor performance status (PS) in almost half of the patients. Overall, 40% of the patients received supportive care at home, and 17% were admitted to a palliative care unit (PCU). Death occurred at home for 17% of the patients and in the PCU for 42% of the patients. CONCLUSION: This study revealed that 13% of histologically proven lung cancer patients were treated with supportive care alone, mostly because of a poor PS. Only 40% of these patients received home care, suggesting the need for a more accessible home care system for patients and their families.
BACKGROUND: It is not uncommon for patients with lung cancer to receive supportive care alone. However, the clinical characteristics of these patients have not been fully studied. We conducted a retrospective study to identify the clinical characteristics of definitive lung cancerpatients treated with supportive care alone. METHODS: We retrospectively analyzed the percentage of and reasons for definitive lung cancerpatients treated with supportive care alone at a regional cancer center. We also investigated the histological diagnostic approaches, palliative therapy types, primary treatment locations after hospital consultation, and places of death. RESULTS: A total of 1,223 patients were histologically diagnosed as having lung cancer between 2011 and 2014. Of these, 160 (13%) patients were treated with supportive care alone. The primary reason for treatment with supportive care alone was a poor performance status (PS) in almost half of the patients. Overall, 40% of the patients received supportive care at home, and 17% were admitted to a palliative care unit (PCU). Death occurred at home for 17% of the patients and in the PCU for 42% of the patients. CONCLUSION: This study revealed that 13% of histologically proven lung cancerpatients were treated with supportive care alone, mostly because of a poor PS. Only 40% of these patients received home care, suggesting the need for a more accessible home care system for patients and their families.
Entities:
Keywords:
Home care; Lung cancer; Palliative care unit; Palliative therapy; Supportive care
Authors: K M Monirul Islam; Xiaqing Jiang; Trisari Anggondowati; Ge Lin; Apar Kishor Ganti Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-11 Impact factor: 4.254
Authors: Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward Journal: Cancer Date: 2013-12-16 Impact factor: 6.860
Authors: Bernardo H L Goulart; Carolina M Reyes; Catherine R Fedorenko; David G Mummy; Sacha Satram-Hoang; Lisel M Koepl; David K Blough; Scott D Ramsey Journal: J Oncol Pract Date: 2013-01 Impact factor: 3.840